Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Rama VI Road, Ratchathewi, Bangkok, 10400, Thailand.
BMC Res Notes. 2021 Apr 17;14(1):145. doi: 10.1186/s13104-021-05558-z.
Prediabetes is prevalent in people living with HIV (PLWH). Insufficient and irregular sleep are linked to abnormal glucose metabolism. This study aimed to investigate the differences in sleep characteristics between PLWH with and without prediabetes, determine the acceptability/feasibility and effects of a pilot six-month intensive lifestyle intervention (ILI) program on glucose metabolism in those with prediabetes, and determine how sleep modulates these effects.
Thirty-nine PLWH (20 normoglycemia and 19 prediabetes) participated. There were no differences in sleep characteristics between individuals with normoglycemia and prediabetes. Next, thirteen individuals with prediabetes completed a six-month ILI program. The ILI program resulted in significant body weight reduction at 6 months (63.5 ± 13.9 to 61.9 ± 14.0 kg, p = 0.012), which was maintained at 12 months (p < 0.001). Waist circumferences were significantly decreased at 12 months (85.4 ± 11.7 to 82.9 ± 12.7 cm, p = 0.014). An increase in sleep variability was significantly associated with an increase in 2-h plasma glucose, independent of changes in BMI (b = 0.603), and physical activity (b = 0.774). This pilot study suggested that ILI in PLWH with prediabetes is feasible and effective in improving metabolic control, with its effects possibly modulated by sleep variability. These findings should be confirmed in a larger study to reduce diabetes risk in this population. Trail registration: ClinicalTrial.gov, NCT03545217 (date of registration: May 22, 2018).
HIV 感染者(PLWH)中普遍存在糖尿病前期。睡眠不足和不规律与葡萄糖代谢异常有关。本研究旨在调查 PLWH 中糖尿病前期与非糖尿病前期人群睡眠特征的差异,确定为期六个月的强化生活方式干预(ILI)计划对糖尿病前期患者葡萄糖代谢的可接受性/可行性及影响,并确定睡眠如何调节这些影响。
39 名 PLWH(20 名血糖正常和 19 名糖尿病前期)参与了研究。血糖正常和糖尿病前期个体的睡眠特征无差异。接下来,13 名糖尿病前期患者完成了为期六个月的 ILI 计划。ILI 计划在 6 个月时显著降低体重(63.5±13.9 至 61.9±14.0kg,p=0.012),并在 12 个月时维持(p<0.001)。腰围在 12 个月时显著减小(85.4±11.7 至 82.9±12.7cm,p=0.014)。睡眠变异性增加与 2 小时血浆葡萄糖增加显著相关,与 BMI(b=0.603)和体力活动(b=0.774)的变化无关。这项初步研究表明,ILI 在糖尿病前期 PLWH 中是可行且有效的,可以改善代谢控制,其效果可能受睡眠变异性的调节。这些发现应在更大的研究中得到证实,以降低该人群的糖尿病风险。临床试验注册:ClinicalTrials.gov,NCT03545217(注册日期:2018 年 5 月 22 日)。